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Purpose: Complex contaminated or infected abdominal wall defects present a particularly challenging
problem to the surgeon. The aim of this study was to describe our experience with human acellular
dermal matrix (ADM) in incarcerated abdominal wall herniorrhaphy.
Methods: We retrospectively reviewed data from 63 patients (51 males and 12 females) who underwent
emergency surgery for acute incarcerated abdominal wall hernias with ADM repair, between June 2008
and October 2011 at Beijing Chaoyang Hospital, Capital Medical University.
Results: All hernias were repaired with an intraperitoneal underlay repair and received a high-vacuum
wound drainage system after herniorrhaphy. 19 patients underwent reinforced repair with component
separation. Over a median follow-up period of 32 (range 13e58) months, the recurrence rate was 4.8%.
Two patients developed bulges, one developed a hematoma, one developed a seroma, and one had a
superﬁcial wound infection. No patients developed ﬁstulae, intestinal obstruction, abdominal pain, or
stiffness of the abdominal wall postoperatively.
Conclusion: Our study suggests that the use of ADM as a biological mesh combined with high-vacuum
wound drainage system in complex abdominal wall reconstruction is acceptable without major side
effects.
 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Synthetic materials are widely used in tension-free repair sur-
gery of abdominal wall hernias, signiﬁcantly reducing the post-
operative recurrence rate. In addition, materials such as
polypropylene and expanded polytetraﬂuoroethylene (ePTFE)
eliminate the need for donor sites and when fully incorporated,
results in a strong and permanent repair. Implantation of a foreign
body, however, is not without potential complications, including
foreign body reaction, ﬁstula formation, surgical site infections,
bowel adhesions, and mesh extrusion [1].
Complex contaminated or infected abdominal wall defects
present a particularly challenging problem to the surgeon [2,3]. It is
well known that implantation of a synthetic mesh into a complex
abdominal wall hernia and other abdominal wall defects, in the
setting of contamination, has a very high complication rate,
including mesh infection, ﬁstula formation, and hernia recurrence
[2,3]. The difﬁcult complication of infected synthetic mesh often
precludes its use in these cases. On the other hand, a staged repair is
associated with a prolonged recovery and high morbidity..com (Z.J. Wang).
lly to this work.
by Elsevier Ltd. All rights reservedRecently, bioprosthetic meshes such as human acellular dermal
matrix (ADM) and porcine small intestinal submucosa have
become available for use in complex abdominal wall reconstruction
[4,5]. ADM is created by removing cellular materials from donated
cadaver skin, leaving a matrix. This matrix consists of a basement
membrane, collagen, elastin, hyaluronan, proteoglycans, ﬁbro-
nectin, and the native tissue’s vascular channels. This bioprosthetic
mesh is especially useful in contaminated or infected ﬁelds,
because the mesh provides a biologic scaffold that allows for native
cellular ingrowth, revascularization, and tissue remodeling [6].
We have applied ADM in treating anal ﬁstulas [7], pelvic ﬂoor
defects after cylindrical abdominoperineal resection [8], rectal de-
fects [9], and complex abdominal wall hernias [10] since June of
2008. We aimed to describe our experience with the use of ADM in
the repair of incarcerated abdominal wall hernias.1. Materials and methods
Data from all patients treated for abdominal wall hernia are
collected in a prospective database at Beijing Chaoyang Hospital,
Capital Medical University. For the current study, we retrospectively
reviewed data from 63 patients who underwent emergency surgery.
Table 1
Characteristics and perioperative data of 63 patients with incarcerated abdominal
wall hernia.
Characteristic Perioperative data
Age (y), median (IQR) 57 (46e-67)
Sex
Male 51 (81%)
Female 12 (19%)
BMI (kg/m2), median (IQR) 29 (26e33)
Current smoker 19 (30.2%)
Diabetes mellitus 12 (19.0%)
Classiﬁcation of the hernia
Grade 3 50 (79.4%)
Grade 4 13 (20.6%)
ASA score
1 9 (14.3%)
2 22 (34.9%)
3 25 (39.7%)
4 7 (11.1%)
Duration of operation (min), median (IQR) 120 (110e150)
Length of hospital stay (d), median (IQR) 9 (8e10)
Defect size (cm2), median (IQR) 96 (48e162)
Type of Incision
Midline 34 (54.0%)
Paramedian 21 (33.3%)
Oblique 8 (12.7%)
Indication for ventral hernia repair
Laparotomy 45 (71.4%)
Recurrence 18 (28.6%)
Bowel resection
Small bowel resection 28 (44.4%)
Large bowel resection 5 (7.9%)
IQR, interquartile range; BMI, body mass index.
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human ADM (Ruinuo; Qingyuanweiye Bio-Tissue Engineering, Ltd;
Beijing, China), between June 2008 and October 2011. Patients with
normal, irreducible abdominal wall hernias were excluded. Accord-
ing to the grading system for the management of incisional ventral
hernias established by the Ventral Hernia Working Group (VHWG)
[11], therewere 50patientswith grade3 and13patientswith grade4
ventral hernias in our study. This study was approved by the insti-
tutional review board of Beijing Chaoyang Hospital and all patients
provided informed consent for use of their data in this study.
Incarcerated abdominal wall hernia repairs were performed by
three experienced surgeons. Prophylactic second-generation
cephalosporins were given 30 min before surgery. All procedures
were performed under general anesthesia. While exploring the
hernia sac and assessing its contents, the operative ﬁeld was pro-
tected from contamination. The intestine was reduced, or necrotic
intestinewas resected. Anastomoseswere performed using double
layer 3/0 Vicryl interrupted suture. The human ADM mesh was
placed under near maximal tension, in an intra-abdominal un-
derlay position, and ﬁxed in place using 0-prolene transfascial
sutures to the abdominal wall. Sutures were placed at least 1 cm
from the edge of the ADM mesh, to avoid tearing of the mesh.
Irrigation of the operative ﬁeld was performed with normal saline
after ADM placement. The use of a component separation to
facilitate primary closure of the fascia was performed in patients
whose primary fascial closure could not be achieved. In these pa-
tients, ADM was also placed in an underlay fashion, using inter-
rupted transfascial mattress sutures.
In general, the mesh was placed with at least 2e3 cm of an
overlap between the mesh and fascia, allowing for distribution of
pressure over a wider area (Pascal’s principle). If the hernia defect
was larger than the size of a single piece of ADM (10 cm  8 cm),
individual sheets were sewn together with permanent mono-
ﬁlament polypropylene sutures in an interrupted or running
fashion.
All patients received a high-vacuum wound drainage system
(Drainobag 600 e B. Braun Melsungen AG, Germany) after
completion of the hernia repair. The drain was placed superﬁcial to
the ADM mesh, and brought out through a separate stab wound.
The skin and subcutaneous tissue were closed without compro-
mising the blood supply. All drains were removed if the drainage
was less than 10e15 ml on 2 consecutive days, or after a maximum
of 14 days, regardless of drainage volume. Patients were encour-
aged to avoid activities that might increase intra-abdominal pres-
sure (severe coughing, straining, etc.) for 3 months postoperatively.
Statistical analysis was performedwith SPSS statistical software,
version 15.0 (SPSS Inc., Chicago, IL). Unless otherwise indicated,
group values were expressed as the median with interquartile
range (IQR). Comparisons between groups were analyzed by the c2
test for categorical variables and the Wilcoxon rank-sum test for
continuous variables. Variables with a P-value of less than .05 by
univariate analysis were entered into a multivariable model (mul-
tiple logistic regression analysis) to identify variables predictive of
bulge and recurrence.
2. Results
The current study includes 63 patients (51 males and 12 fe-
males) with incarcerated abdominal wall hernias who underwent
ADM repair. The median age was 57 years and the median body
mass index (BMI) was 29. Most defects were attributed to a pre-
vious midline laparotomy incision (71.4%). More than 50 percent of
our patients had American Society of Anesthesiologists scores 3
and 12 patients were diabetics. The demographic characteristics of
our patients are summarized in Table 1.22 patients underwent repair with one sheet of 10 cm  8 cm
ADM mesh, 11 with two sheets of 10 cm  8 cm ADM mesh, sewn
together using continuous sutures (2/0 prolene suture material), 17
with three sheets, and 13 with four sheets for large abdominal wall
defects. Lateral component separationwas performed and the ADM
was placed as a reinforcement graft in 19 of 63 patients.
The median follow-up period for patients was 43 (range 24e69)
months. A CT was performed if the patient was considered to have
recurrence or bulge; bulges were differentiated from recurrence by
the absence of hernia sacs. Ten patients developed recurrences
(15.9%), eight patients developed bulges (12.7%), and all refused
further surgical intervention. Three patients developed seromas
(4.8%) that resolved by percutaneous drainage. One patient had a
superﬁcial wound infection (1.6%) that was treated with local
wound care and allowed to heal by secondary intention (Table 2).
No patients developed ﬁstulas, intestinal obstruction, or abdominal
pain postoperatively. There were no deaths in our study.
We evaluated potentially signiﬁcant patient factors and surgical
techniques that contributed to our complication rate. Comparison
of patients with bulge and recurrence vs. those without bulge and
recurrence (Table 3) demonstrated the following variables to be
associated with bulge and recurrence: high BMI (P ¼ 0.001), large
defect size (P < 0.001), numbers of biological meshes used
(P ¼ 0.018), and indication for ventral hernia (P ¼ 0.005). Multi-
variate analysis (Table 4) demonstrated three factors to be signiﬁ-
cantly related to bulge and recurrence: BMI (P ¼ 0.008), defect size
(P ¼ 0.016), and numbers of biological meshes used (P ¼ 0.027).
Other factors did not signiﬁcantly affect recurrence rate.3. Discussion
The use of prosthetic materials has been successful in uncom-
plicated anterior abdominal wall reconstruction [12]. Most pros-
thetic mesh implantations today are composed of permanent
Table 2
Postoperative complications in 63 patients with incarcerated abdom-
inal wall hernia.
Complications n (%)
Recurrence 10 (15.9%)
Bulge 8 (12.7%)
Seroma 3 (4.8%)
Superﬁcial wound infection 1 (1.6%)
Pneumonia 1 (1.6%)
Urinary system infection 1 (1.6%)
Deep vein thrombosis 1 (1.6%)
Table 4
Multiple logistic regression analyses of potential predictors of bulge and recurrence.
Variables Or (95% CI) P
BMI .777 (.6455e.936) .008
Defect size 1.021 (1.004e1.039) .016
Numbers of biological mesh .160 (.031e.809) .027
Indication for ventral hernia repair .236 (.038e1.457) .120
BMI, body mass index.
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ethylene (PTFE). Unfortunately, these materials are at high risk for
infectionwhenused in a contaminatedﬁeldand therefore their use is
not recommended in these situations [2,3]. When infection occurs,
the current approach is wound debridement, drainage, and even
excision of infected mesh. Rodgers et al. suggested that prosthetic
materials possess the advantage of ready availability, but the disad-
vantage of acting as a residual foreign body, susceptible to infection
[13]. Similarly, Houck et al. [14] concluded that repair of incisional
hernias had a signiﬁcantly higher rate of infection than other clean
general surgical procedures. Herniorrhaphy of a wound that was
previously infected was at a high risk for reinfection, despite com-
plete healingof the skin andabsenceof clinical signs of infection [14].
Insertion of biologic fascial substitutes is now available. One
material, human acellular dermal matrix (ADM), offers a potentially
attractive option for one-stage repair of abdominal wall defects in
the setting of contamination [4]. The ADM used in our study was
packaged moistly and aseptically, and must be stored under 2e8 C
[15], which was different from Alloderm (Lifecell company). ADM is
decellularized human dermis that removes the epidermis and the
cellular components of the dermis, leaving the basement mem-
brane components, including type I and II collagen, elastin, and
laminin, which are undamaged within the residual dermal matrix.
Its biggest beneﬁt is its tolerance of infectionwithout breakdown or
loss of strength. Our study demonstrates that ADM does become
revascularized when used as a fascial interposition graft for
abdominal wall reconstruction and also performs mechanically asTable 3
Characteristics in relation to bulge and recurrence.
Variables Bulge and
recurrence
(n ¼ 18)
No bulge and
recurrence
(n ¼ 45)
P
Age (years), median (IQR) 57 (45e65) 57 (46e68) .652
BMI (kg/m2), median (IQR) 32.5 (29.0e36.0) 28.0 (25.0e33.0) .001
Gender, Male to female ratio
Female 5 7
Male 13 38 .447
Smoking, n (%) 7 (38.9) 18 (40.0) .705
Alcohol consumption, n (%) 4 (22.2) 7 (15.6) .793
Diabetes mellitus, n (%) 3 (16.7) 6 (13.3) 1.000
Blood glucose level
(mmol/L), median (IQR)
6.87 (6.11e6.87) 6.73 (6.73e7.29) .750
Chronic cough (COPD), n (%) 3 (16.7) 5 (11.1) .858
Heavy physical work 2 (11.1) 3 (6.67) .941
Defect size (cm2),
median (IQR)
55 (37.5e121) 128 (64.0e168.0) <.001
Bowel resection 12 21 .262
Numbers of biological mesh
Individual 2 20
Sewn together 16 25 .018
Previous operation of
ventral hernia
Laparotomy 8 37
Recurrence 10 8 .005
IQR, interquartile range; BMI, body mass index; COPD, chronic obstructive pulmo-
nary disease.effectively as prosthetic mesh in vental hernia repairs [16]. This
makes it an ideal material to implant into already infected wounds
or wounds that are at high risk for infection [4,16e19].
ADM has been used for contaminated abdominal wall defects
for several years. Although some investigators have reported
favorable results, others have noted problems with superﬁcial or
deep space wound infection, seromas, ﬁstula formation, hernia
recurrence, and the need for frequent repeat surgeries [20]. The
main wound complications in our study were seroma formation in
3 patients (4.8%) and superﬁcial wound infection in the others
(2.8%); they responded to conservative treatments. Other authors
reported that vacuum-assisted closure technique might be advan-
tageous for the prevention of postoperative wound complications
[21,22]. We suspect that the reason for the low rate of seroma
formation and wound infection in this trial might be the use of the
high-vacuum wound drainage system after completion of the
repair. When no postoperative suction drains were used, the inci-
dence of seromas and wound infection were found to be unac-
ceptably high, in various studies inwhich seroma formation (15.4%)
and superﬁcial wound infection (15.4%) were reported in patients
with parastomal hernia reconstructed with human ADM [23]. A
meta-analysis of outcomes using acellular dermal matrix in
abdominal wall reconstructions reported that seroma formation
and wound infection were as high as 11.8% and 24.6%, respectively
[24]. The vacuum wound drainage system was widely used after
mastectomy, and was reported to be relatively inexpensive, and
efﬁcient for seroma drainage, reducing hospital stay signiﬁcantly
without any increase in the postoperative morbidity [25,26]. For
the ﬁrst time w, we used the high vacuumwound drainage system
in the reconstruction of complex abdominal wall hernias using
ADM to prevent seroma formation and wound infection, and ach-
ieved satisfactory results. The mechanism proposed might be that
suction helps the ADM to adhere to the abdominal wall, sealing off
all the hematoma, seroma, and infectious ﬂuids. We suggest that
the high vacuum wound drainage system might prevent hema-
toma, seroma, and infection formation, and reduce hospital stay
after ADM implantation, making a pressure dressing unnecessary
[26e28].
The only technique used with ADM for abdominal wall recon-
struction in our study was intra-abdominal underlay, in which 10
patients had a hernia recurrence (15.9%). 12 patients received
reinforced repair with component separation in this trial, and the
rest received primary closure of the fascia, together with biological
mesh closure. Several techniques have been described such as
underlay, sublay, interposition, onlay, and sandwiched (underlay
and onlay). There was a statistically signiﬁcant recurrence in the
patients repaired with ADM used as an interposition or overlay
[4,29]. Several studies observed that ADM used as an underlay had
the lowest incidence of recurrence compared with that used as
interposition or onlay [30,31], and another study suggested that
underlay mesh placement resulted in a similar recurrence rate to
sublay positioning [32]. Recurrence rates of ADM mesh as an un-
derlay varied widely among studies, from 0 to 23.3 percent
[4,31,33e35]. Diaz et al. [33] reported a hernia recurrence rate of
18.7% associated with the use of ADM as an underlay over a mean
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size was 168 cm [2], which was much larger than in our study
(96 cm2). Furthermore, techniques for reinforcement of fascial re-
pairs with ADM (bridged or reinforced) were found to be important
in determining strength of the reconstruction. Jin et al. [36] found
that ADM used in a reinforced repair with component separation
was signiﬁcantly superior to a bridged repair without component
separation, and proposed that ADM should be used only as a
reinforcement after primary component separation. We believe
that smaller defect size, using underlay and a reinforced repair
technique, using an appropriate amount of mesh and fascia overlap,
suturing at least 1 cm from the edge of the mesh and placing the
mesh under signiﬁcant tension, may have contributed to our low
recurrence rate.
Three factors were found to correlate with hernia bulge and
recurrence in our study: body mass index, defect size, and numbers
of biological meshes used. Besides the repair technique, a system-
atic review of original incisional hernia studies showed factors
which effect hernia recurrence rates to include infection, bodymass
index, and reconstructing a failed prior repair [37]. In our study,
prior hernia repair was found to correlate with hernia bulge and
recurrence in the univariate analysis; however, this was not sta-
tistically signiﬁcant inmultiple logistic regression analyses. We also
found that the number of biological meshes used was associated
with a higher bulge and recurrence rate, while all recurrences were
noted to originate from the fascial to graft interface and did not
appear to be related to graft-to-graft sutures, as consistent in Patton
et al.’s study [4].
Although abdominal wall laxity, resulting in bulge is one of the
familiar complications following ADM reconstruction, there were
only 8 bulges (12.7%) reported in this retrospective study. Glasberg
et al. [38] suggested that hernias have sacs with an acute angle
between the sac and abdominal wall, while bulges do not have sacs;
the angle between the protruding area and the abdominal wall is
obtuse and there was a 21% rate of abdominal wall bulge after a
mean follow-up period of 18.5 months. Gupta et al. [39] reported
their experience with ADM used as interposition, overlay and un-
derlay repairs for ventral hernia. They reported that ADM had a
high rate of abdominal wall laxity (45%), with laxity becoming
evident as late as 18 months postoperatively. Candage et al. [40]
found that the incidence of bulge increased signiﬁcantly when
ADMwas used in a bridged repair, compared with reinforced repair
(35% vs. 3.8%, P¼ 0.014). BluebondeLangner et al. [41] reported that
the abdominal wall laxity occurred more frequently in large
abdominal wall defects or following surgical site infections. Diaz Jr.
et al. [33] supposed that during implantation, ADM must be placed
under a great deal of tension. If the elasticity in ADM is inade-
quately addressed during the repair, laxity of the repair may occur.
Aside from implantation of ADM under tension, the type of suture
material used may also lead to improved long-term outcomes [30].
4. Conclusion
This study suggests that the use of ADM as a biological mesh
combined with a high-vacuumwound drainage system in complex
abdominal wall reconstruction is acceptable without major side
effects. Further studies should evaluate the long-term outcomes of
ADM, establish the indications for ADM use, and clarify patient
selection factors to identify those who would beneﬁt the most.
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